Company profile

Freenome

Outpacing cancer starts with early detection

Industry
Biotechnology Research
Employees
405
Headquarters
Brisbane, California
Founded
2014
LinkedIn followers
47,256
Office locations
1

Freenome company summary

Freenome is a company in the Biotechnology Research industry, headquartered in Brisbane, California, founded in 2014. On LinkedIn the company has around 405 employees and 47,256 followers. Its listed specialties include molecular diagnostics, multiomics, machine learning, biotechnology, cancer screening.

What technology does Freenome use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Freenome

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

Specialties

molecular diagnosticsmultiomicsmachine learningbiotechnologycancer screeningoncologyearly cancer detectioncomputational biology

Where is Freenome located?

Freenome lists 1 location.

Brisbane, California, USHQ
3300 Marina Blvd

Compare companies similar to Freenome

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Freenome
freenome.com
Biotechnology Research4052014Brisbane, California
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Freenome

What does Freenome do?

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

How many employees does Freenome have?

Freenome has around 405 employees on LinkedIn.

Where is Freenome headquartered?

Freenome is headquartered in Brisbane, California.

When was Freenome founded?

Freenome was founded in 2014.

Build a lead list from companies like Freenome

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.